{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:48:32Z","timestamp":1759366112162,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.eimc.2019.09.004","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T09:09:48Z","timestamp":1573808988000},"page":"200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["R\u00e9plica a \u00abProbable hipocalemia secundaria al tratamiento con ceftolozano\/tazobactam: a prop\u00f3sito de 3 casos\u00bb"],"prefix":"10.1016","volume":"38","author":[{"given":"Javier Miguel","family":"Mart\u00edn-Guerra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Mart\u00edn-Asenjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2019.09.004_bib0045","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eimc.2018.06.013","article-title":"Hypokalaemia probably associated with ceftolozane\/tazobactam treatment: Three case reports","volume":"37","author":"Toro Blanch","year":"2019","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.eimc.2019.09.004_bib0050","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS). Centro de Informaci\u00f3nn de Medicamentos (CIMA). Ficha t\u00e9cnica Zerbaxa [consultado 8 Sep 2019]. Disponible en: https:\/\/cima.aemps.es\/cima\/pdfs\/es\/ft\/1151032001\/FT1151032001.pdf"},{"key":"10.1016\/j.eimc.2019.09.004_bib0055","first-page":"56","article-title":"Approach to hypokalemia","volume":"39","author":"Lim","year":"2007","journal-title":"Acta Med Indones."},{"key":"10.1016\/j.eimc.2019.09.004_bib0060","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/bmj.4.5630.550","article-title":"Hypokalaemia, metabolic alkalosis, and hypernatraemia due to \u00abmassive\u00bb sodium penicillin therapy","volume":"4","author":"Brunner","year":"1968","journal-title":"Br Med J"},{"key":"10.1016\/j.eimc.2019.09.004_bib0065","first-page":"528","article-title":"Hypokalemic, metabolic alkalosis induced by high-dose ampicillin sodium","volume":"34","author":"Gill","year":"1977","journal-title":"Am J Hosp Pharm."},{"key":"10.1016\/j.eimc.2019.09.004_bib0070","first-page":"OD05","article-title":"Meropenem induced hypokalemia","volume":"11","author":"Anuhya","year":"2017","journal-title":"J Clin Diagn Res."},{"key":"10.1016\/j.eimc.2019.09.004_bib0075","first-page":"745","article-title":"Meropenem: A unusual cause of metabolic alkalosis in critical care patients","volume":"36","author":"Bhagwat","year":"2008","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.eimc.2019.09.004_bib0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/0970-9185.75131","article-title":"Meropenem in critical care - Uncovering the truths behind weaning failure","volume":"26","author":"Bharti","year":"2010","journal-title":"J Anaesth Clin Pharmacol"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X19302368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X19302368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:06:05Z","timestamp":1759323965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X19302368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0213005X19302368"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2019.09.004","relation":{},"ISSN":["0213-005X"],"issn-type":[{"type":"print","value":"0213-005X"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"R\u00e9plica a \u00abProbable hipocalemia secundaria al tratamiento con ceftolozano\/tazobactam: a prop\u00f3sito de 3 casos\u00bb","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2019.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2018.06.013","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}